Aigen Investment Management, LP Coherus Bio Sciences, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.02 - $3.14 $26,916 - $41,840	13,325 New	13,325 $31,000
Q2 2021 Aug 10, 2021	SELL	$12.95 - $15.41 $605,218 - $720,186	-46,735 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$14.42 - $21.39 $308,530 - $457,660	21,396 Added 84.44%	46,735 $683,000
Q4 2020 Feb 12, 2021	BUY	$16.56 - $18.94 $101,943 - $116,594	6,156 Added 32.09%	25,339 $440,000
Q3 2020 Nov 06, 2020	SELL	$17.41 - $19.89 $259,948 - $296,977	-14,931 Reduced 43.77%	19,183 $352,000
Q2 2020 Aug 10, 2020	BUY	$14.43 - $19.16 $492,265 - $653,624	34,114 New	34,114 $609,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.